Skip to main content
. 2020 Sep 18;20(5):255. doi: 10.3892/ol.2020.12118

Figure 5.

Figure 5.

Enrichment plots from gene set enrichment analysis. (A) VEGF pathway, (B) PTEN pathway, (C) PDGF pathway, (D) ATR and BRCA pathway, (E) CARM and ER pathway, (F) DNA repair, (G) KRAS signaling pathway, (H) PI3K-AKT-mTOR signaling pathway, and (I) the G2M checkpoint were differentially enriched in SCGB2A1-associated uterine corpus endometrial carcinoma. VEGF, vascular endothelial growth factor; PDGF, platelet-derived growth factor; ATR, ataxia-telangiectasia and Rad3-related; CARM, coactivator associated arginine methyltransferase; ER, estrogen receptor; SCGB2A1, secretoglobin family 2A member 1.